Objective
Research is being done to understand the mechanism of cellular immunity in swine protection against different viral diseases and to develop new vectors for vaccine development. This work is based on the use of a cloned bacterial outer membrane lipoprotein (from Pseudomonas aeruginosa) as a vector to make fusion proteins containing protective epitopes, in view of the development of subunit and/or live vaccines against important swine diseases such as Affican swine fever (ASF). The lipoprotein presents several advantages, such as small molecular weight, localization in the membrane, high expression and binding to peptidoglycan (a natural adjuvant).
4 vectors have beendeveloped based on the lipoprotein gene of Pseudomonas aeruginosa containing different cloning sites. Monoclonal antibodies against the lipoprotein have been produced and characterized. ASF virus particles have been produced from strain Lisbon 60 in pig macrophages. ASF virus deoxyribonucleic acid (DNA) has been purified and purity controlled in restriction mapping. Haelll fragments of ASF virus DNA have been shotgun cloned in the engineered Hpal site of one Lpp vector. Positive clones have been detected by colony hybridization using digoxigenin labelled ASF virus DNA, in the presence of excess of pig DNA. The clones have been confirmed using an antibody which recognizes the lipoprotein but not fusion proteins. Clones have been detected which produce membrane bound fusion proteins by sodium dodecyl dulphat-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot using another monoclonal antibody whose epitope is not disrupted by the introduction of new amino acids in the Lpp sequence. 2 large fusion proteins have been obtained so far, one of 29 kDa and one of 0 kDa (size of the Lpp was 7 kDa).
The project is based on the use of a cloned bacterial outer membrane lipoprotein (from Pseudomonas aeruginosa) as a vector to make fusion proteins containing protective epitopes in view of the development of subunit and/or live vaccines against important swine diseases like African Swine Fever (ASF). The lipoprotein presents several advantages, i.e. a small molecular weight, localisation in the membrane, high expression, binding to peptidoglycan (a natural adjuvant).
More specifically, the vector will be manipulated by inserting polylinkers to facilitate the cloning of viral DNA and cloned in a vector for controlled expression under the dependence of the lac promoter. DNA fragments from the strain Lisbon 60 of ASF will be cloned and expression of epitopes detected with an anti ASF serum. The important ASF viral epitopes inducing non-specific and specific cellular immune defense mechanisms will be tested by natural killer (N/K) cell activity, lymphoproliferative responses and CTL activity.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences genetics DNA
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- natural sciences chemical sciences organic chemistry amines
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Data not available
Coordinator
1640 ST. GENESIUS RODE
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.